Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_assertion type Assertion NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_head.
- NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_assertion description "[Vasoactive intestinal peptide (VIP) exerts similar effects in prostate cancer models involving increased expression of vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) which are related to NF-?B transactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_provenance.
- NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_assertion evidence source_evidence_literature NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_provenance.
- NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_assertion SIO_000772 25446255 NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_provenance.
- NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_assertion wasDerivedFrom befree-2016 NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_provenance.
- NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_assertion wasGeneratedBy ECO_0000203 NP1242090.RA_g0etSULautbwWyi2YmDUipBPQT6Uv1pujvza-v2nak130_provenance.